These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6215342)

  • 1. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
    De Weger RA; Pels E; Den Otter W
    Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte induced macrophage cytotoxicity: characterization of the macrophage cytotoxicity-inducing lymphocyte.
    Pels E; de Weger RA; den Otter W
    Immunobiology; 1984 Jan; 166(1):84-95. PubMed ID: 6201434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A macrophage factor enhancing the systemic anti-tumour effect of T lymphocytes.
    van Loveren H; de Groot JW; Koten JW; Piersma AH; de Weger RA; den Otter W
    Immunobiology; 1984 Mar; 166(2):118-30. PubMed ID: 6609876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.
    Dullens HF; Vuist W; Van der Maas M; Den Otter W
    Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two specific T cell factors that initiate immune responses in murine allograft systems. A comparison of biologic functions.
    Vandebriel RJ; De Weger RA; Los G; Van Loveren H; Wiegers GJ; Oude Weernink PA; Den Otter W
    J Immunol; 1989 Jul; 143(1):66-73. PubMed ID: 2659669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
    Pels E; De Weger RA; Den Otter W
    Int Arch Allergy Appl Immunol; 1984; 74(2):140-6. PubMed ID: 6609130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between cytotoxic activity and delayed hypersensitivity against syngeneic or allogeneic tumor grafts.
    Sato M; Nomoto K; Yano Y; Taniguchi K; Takeya K
    Gan; 1976 Dec; 67(6):835-47. PubMed ID: 1088135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
    J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage killing capacity. Aspects of mechanism.
    Gallily R; Eliahu H; Ben-Ishay Z
    Adv Exp Med Biol; 1976; 66():471-6. PubMed ID: 57706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific augmentation of delayed-type hypersensitivity by immune serum factor in mice: augmentation of anti-tumor cytostatic activity.
    Nakamura S; Himeno K; Yamada A; Mitani M; Nomoto K
    Cell Immunol; 1986 Dec; 103(2):311-25. PubMed ID: 3542236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    Biondi A; Roach JA; Schlossman SF; Todd RF
    J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophages.
    Treves AJ; Heidelberger E; Feldman M; Kaplan HS
    Isr J Med Sci; 1979 Jul; 15(7):564-9. PubMed ID: 478818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
    Panosian CB; Sypek JP; Wyler DJ
    J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.